A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Background The seroprevalance of SARS-COV-2 infection have been studied in immunocompetent children. However, data in pediatric Kidney Transplant population (PKT) is lacking. Methods We screened 72 PKT patients who came for routine blood work in the outpatient clinic using two commercial immunoassays that measures IgG antibodies against SARS-COV-2 spike protein and IgG against the Nucleocapsid protein. Majority of patients with positive serology had their serology test repeated at least oncedoi:10.21203/rs.3.rs-140932/v1 fatcat:ekl37zbwgjeu5g4xzzoi7cuevq